The US Food and Drug Administration (FDA) has granted approval for Abbott’s Volt PFA System, expanding treatment options for patients with atrial fibrillation (AFib). The approval follows earlier CE ...

The FDA approved Abbott's Volt PFA System for atrial fibrillation, supported by VOLT-AF trial data showing strong safety and ...

Abstract: Accurate classification of atrial arrhythmias from single-lead ECG recordings presents significant clinical challenges, particularly for atrial flutter (AFL) subtypes characterized by ...

As the holiday season ramps up with parties, big meals and celebratory drinks, doctors are reminding men not to ignore their ...

Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced it has received FDA 510(k) clearance for its next-generation vMap® technology. The clearance expands ...

Pirtobrutinib showed noninferiority in ORR compared to ibrutinib in BTK inhibitor-naive CLL/SLL patients, with a favorable PFS trend. Safety profiles indicated fewer adverse events with pirtobrutinib, ...

Targeted therapies and immunotherapies are increasingly offering viable alternatives to the chemotherapies that have stood for decades as a mainstay of treatment for individuals living with blood ...

Background: Cavotricuspid isthmus (CTI) ablation is the preferred treatment for typical atrial flutter, performed using various techniques. This study aimed to compare procedural and follow-up data ...

Correspondence to Dr Yuichiro Minami, Department of Cardiology, Tokyo Women's Medical University, Tokyo 162-8666, Japan; yuichiro24{at}celery.ocn.ne.jp If you wish to reuse any or all of this article ...